| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
IRD
Opus Genetics
|
Jun 17, 2026 | BUY |
Strong Buy
+155.2% avg upside
23 analysts
|
$10.00
146.38% Upside
|
· |
|
SVRA
Savara
|
Jun 09, 2026 | BUY |
Strong Buy
+60.7% avg upside
17 analysts
|
$10.00
85.97% Upside
|
· |
|
DFTX
Definium Therapeutics
|
Jun 06, 2026 | BUY |
Strong Buy
+46.3% avg upside
20 analysts
|
$44.00
80.02% Upside
|
+6.1% |
|
DYN
Dyne Therapeutics
|
Jun 03, 2026 | BUY |
Strong Buy
+98.3% avg upside
29 analysts
|
$44.00
129.25% Upside
|
+4.1% |
|
CMPS
COMPASS Pathways
|
Jun 02, 2026 | BUY |
Strong Buy
+68.1% avg upside
18 analysts
|
$23.00
92.62% Upside
|
-10.4% |
|
PRAX
Praxis Precision Medicines
|
Jun 02, 2026 | BUY |
Strong Buy
+96.4% avg upside
24 analysts
|
$731.00
170.67% Upside
|
+3.2% |
|
OVID
Ovid Therapeutics
|
May 16, 2026 | BUY |
Strong Buy
+98.5% avg upside
17 analysts
|
$5.00
106.56% Upside
|
· |
|
LRMR
Larimar Therapeutics
|
May 16, 2026 | BUY |
Strong Buy
+421.7% avg upside
21 analysts
|
$25.00
606.26% Upside
|
+4.9% |
|
MPLT
MapLight Therapeutics, Inc.
|
May 15, 2026 | BUY |
Strong Buy
+30.8% avg upside
11 analysts
|
$45.00
54.02% Upside
|
-5.5% |
|
AQST
Aquestive Therapeutics
|
May 15, 2026 | BUY |
Strong Buy
+100.1% avg upside
10 analysts
|
$9.00
103.07% Upside
|
+3.2% |
|
TARS
Tarsus Pharmaceuticals
|
May 09, 2026 | BUY |
Strong Buy
+21.3% avg upside
16 analysts
|
$95.00
51.86% Upside
|
+6.9% |
|
CNTA
Centessa Pharmaceuticals
|
Apr 01, 2026 | HOLD |
Buy
-14.1% avg upside
19 analysts
|
— | -0.0% |
|
KALA
KALA BIO
|
Oct 24, 2025 | HOLD |
Strong Buy
+7343.1% avg upside
9 analysts
|
— | -93.4% |
|
HRMY
Harmony Biosciences Holdings
|
Apr 08, 2025 | BUY |
Strong Buy
+38.7% avg upside
13 analysts
|
$61.00
80.73% Upside
|
+1.2% |
|
SLP
Simulations Plus
|
Apr 04, 2025 | BUY |
Buy
+89.9% avg upside
11 analysts
|
$65.00
256.22% Upside
|
-53.3% |
|
FTH
Faeth Therapeutics
|
Mar 28, 2025 | BUY |
Strong Buy
+121.6% avg upside
11 analysts
|
$80.00
380.55% Upside
|
· |
|
ABEO
Abeona Therapeutics
|
Mar 20, 2025 | BUY |
Strong Buy
+200.8% avg upside
17 analysts
|
$16.00
183.25% Upside
|
-13.4% |
|
ALDX
Aldeyra Therapeutics
|
Mar 03, 2025 | BUY |
Strong Buy
+753.6% avg upside
21 analysts
|
$12.00
555.75% Upside
|
-15.7% |
|
TRDA
Entrada Therapeutics Inc
|
Feb 28, 2025 | BUY |
Strong Buy
+210.2% avg upside
10 analysts
|
$30.00
340.56% Upside
|
-0.1% |
|
ACHV
Achieve Life Sciences
|
Jan 08, 2025 | BUY |
Strong Buy
+194.1% avg upside
12 analysts
|
$11.00
105.26% Upside
|
+55.4% |
|
BCRX
BioCryst
|
Aug 26, 2024 | HOLD |
Strong Buy
+102.2% avg upside
24 analysts
|
— | +4.2% |
|
HELP
Helus Pharma
|
Aug 26, 2024 | HOLD |
Strong Buy
+884.5% avg upside
12 analysts
|
— | · |
|
MDWD
Mediwound
|
Jul 29, 2024 | BUY |
Strong Buy
+52.4% avg upside
13 analysts
|
$36.00
153.60% Upside
|
+2.4% |
|
DMAC
Diamedica Therapeutics
|
Jul 01, 2024 | BUY |
Strong Buy
+158.2% avg upside
12 analysts
|
$6.00
4.69% Upside
|
+21.0% |
|
BNGO
BioNano Genomics
|
Aug 17, 2023 | BUY |
Strong Buy
+713.5% avg upside
9 analysts
|
$20.00
1624.23% Upside
|
-82.2% |
|
PCSA
Processa Pharmaceuticals
|
Apr 03, 2023 | BUY |
Strong Buy
+1986.4% avg upside
5 analysts
|
$60.00
2690.68% Upside
|
-75.7% |
|
SERA
Sera Prognostics
|
Mar 23, 2023 | BUY |
Strong Buy
+300.0% avg upside
7 analysts
|
$5.00
164.46% Upside
|
+163.8% |
|
NMTRQ
9 Meters Biopharma
|
Sep 27, 2022 | BUY |
Buy
+3234374900.0% avg upside
11 analysts
|
$100.00
9999999900.08% Upside
|
· |
|
MDXH
MDxHealth
|
Jul 18, 2022 | BUY |
Strong Buy
+1037.7% avg upside
8 analysts
|
$18.00
3104.56% Upside
|
-48.5% |
|
CELC
Celcuity
|
May 11, 2020 | BUY |
Strong Buy
+41.4% avg upside
16 analysts
|
— | · |
|
GLMD
Galmed Pharmaceuticals
|
Feb 04, 2020 | BUY |
Buy
+3982.5% avg upside
13 analysts
|
$18.00
2898.94% Upside
|
-18.7% |
|
TLSA
Tiziana Life Sciences
|
Sep 10, 2019 | BUY |
Strong Buy
+525.8% avg upside
5 analysts
|
$4.00
270.39% Upside
|
+136.0% |
|
EBS
Emergent Biosolutions
|
Sep 04, 2019 | BUY |
Buy
+211.6% avg upside
9 analysts
|
$72.00
784.57% Upside
|
+87.1% |
|
ARDS
Aridis Pharmaceuticals
|
Sep 04, 2019 | BUY |
Strong Buy
+427319.4% avg upside
5 analysts
|
$15.00
483770.93% Upside
|
-40.8% |
|
CLSDQ
Clearside Biomedical
|
Aug 22, 2019 | HOLD |
Hold
+139900.0% avg upside
10 analysts
|
$1.00
4900.10% Upside
|
+134.9% |
|
SDEV
Stablecoin Development Corp
|
Jul 29, 2019 | HOLD |
Buy
+8.1% avg upside
7 analysts
|
$1.00
15.95% Downside
|
· |
|
MTVA
MetaVia
|
Jun 27, 2019 | BUY |
Strong Buy
+1656.7% avg upside
13 analysts
|
$50.00
2823.97% Upside
|
-54.6% |
|
STEX
Streamex
|
Feb 20, 2019 | BUY |
Strong Buy
+905.0% avg upside
5 analysts
|
$10.50
1025.72% Upside
|
· |
|
TVRD
Tvardi Therapeutics
|
May 24, 2018 | BUY |
Buy
+601.3% avg upside
23 analysts
|
$26.00
907.69% Upside
|
+16.0% |
|
HEPA
Hepion Pharmaceuticals
|
Feb 13, 2018 | BUY |
Strong Buy
+62892.6% avg upside
9 analysts
|
$210.00
262399.94% Upside
|
· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.